HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Molecular tumor testing transformative, yet 'under-optimized' Jennifer R. Southall
-
- Should there be universal molecular testing for all patients with gastrointestinal cancer?
- Hematology/oncology APP onboarding important to 'close the knowledge gap' Camille Petraitis Valente, DNP, FNP-BC
- COVID-19’s possible upside: More children getting active outside Nicholas J. Petrelli, MD, FACS
- Adding nivolumab to neoadjuvant chemotherapy does not impede surgery in resectable NSCLC Jennifer R. Southall
- Adjuvant chemotherapy after chemoradiation fails to extend OS in cervical cancer subset Jennifer R. Southall
- Adjuvant olaparib significantly extends DFS in early breast cancer subtype Alexandra (Sasha) Todak
- Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors Alexandra (Sasha) Todak
- Aspacytarabine a potential first-line option for chemotherapy-ineligible patients with AML Ryan Lawrence
-
- BCMA-directed CAR-T shows ‘impressive’ durability for advanced multiple myeloma Drew Amorosi
- Black women more likely to develop distant metastases from breast cancer Mark Leiser
- Copanlisib regimen improves outcomes in pretreated follicular, marginal zone lymphoma Mark Leiser
- Fixed-duration ibrutinib-venetoclax induces deep responses in treatment-naive CLL Mark Leiser
- Immediate-read mammography program reduces disparities, ‘eliminates a huge barrier’ Jennifer Byrne
- Lisinopril may prevent cardiotoxicity of anthracycline, trastuzumab use in breast cancer Alexandra (Sasha) Todak
- Luspatercept safe, effective in nontransfusion-dependent beta-thalassemia Jennifer R. Southall
- Oncologist advises ‘do your homework’ when making career decisions Talitha Bennett
-
- Pembrolizumab after nephrectomy extends DFS in high-risk clear cell renal cell carcinoma Ryan Lawrence
- Preoperative pembrolizumab may enhance major pathologic response in esophageal cancer Ryan Lawrence
- Research sites to test tools aimed at improving diversity in cancer clinical trials Jennifer Byrne
- Sotorasib shows activity in NSCLC with KRAS mutations Alexandra (Sasha) Todak
- Zanubrutinib outperforms ibrutinib in advanced CLL, small lymphocytic lymphoma Jennifer R. Southall
- Oncologist recognized as one of nation’s top cancer leaders
- Roswell Park names first chief diversity, equity officer for faculty
- Mount Sinai appoints chief of hematology and medical oncology
-
- Sidney Kimmel Cancer Center — Jefferson Health names deputy director
- Memorial Sloan Kettering staff members honored for nursing excellence
- Cedars-Sinai Cancer names thoracic medical oncology director
- Advisory panel recommends FDA defer decision on retifanlimab for anal cancer Jennifer R. Southall
- Maribavir receives priority review for refractory CMV infection
- Radioligand therapy for prostate cancer receives breakthrough designation